Resistance to emtricitabine 23 times more likely in former PrEP users, but no resistance to tenofovir A case note review from 56 Dean Street, the largest HIV and STI clinic in Europe, has found that former PrEP users who get HIV are more likely to have a certain type of drug resistance than people who… Read More »
The internet is rife with funny cat videos showing their reactions to a plant commonly known as “catnip.” What is catnip, does it affect all felines, is it safe for cats, and should humans use it? This Special Feature investigates these questions and more. Share on PinterestDoes your feline friend go crazy for catnip? In… Read More »
Many of the existing diseases that strike us are poorly treated not because effective drugs don’t exist, but because there’s no reliable way of delivering the drugs to their intended destinations. Anyone following this publication will be familiar with the dozens of types of synthetic vessel that scientists have created to ferry drugs to tumors,… Read More »
After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, AMAG’s sudden decision to cut ties with its chief executive could be akin to shifting “deck chairs on the Titanic,” one analyst said. AMAG… Read More »